ProKidney Corp. Earnings
The next earnings date for ProKidney Corp. has not yet been scheduled.
Analyst Estimates of ProKidney Corp. Earnings
| No results. | |
What is an Earnings Date
An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.
Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.
Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.
ProKidney Corp. Earnings: Historical
| 08/10/2026 | After Market | $-0.15 | -15.38% |
| 05/15/2026 | --- | $-0.14 | -1.82% |
| 03/18/2026 | After Market | $-0.14 | 6.67% |
| 11/10/2025 | After Market | $-0.12 | 14.29% |
| 08/12/2025 | After Market | $-0.13 | 7.14% |
| 05/12/2025 | --- | $-0.13 | 18.75% |
| 03/17/2025 | Before Market | $-0.17 | -13.33% |
| 11/12/2024 | Before Market | $-0.14 | 36.36% |
| 08/09/2024 | Before Market | $-0.16 | 11.11% |
| 05/10/2024 | After Market | $-0.16 | 11.11% |
More About ProKidney Corp.
ProKidney Corp., a clinical-stage biotechnology company, engages in the development of cell therapies for the treatment of chronic kidney diseases in the United States. The company develops rilparencel, a cell therapy with autologous selected renal cells, which is in Phase III clinical trial for the treatment of advanced chronic kidney disease and type 2 diabetes. It is also involved in the development of cryopreserved versions of rilparencel, including REGEN-006 and REGEN-008 which are both in Phase III clinical trials; REGEN-002, REGEN-003, and REGEN-007 which are in Phase II clinical trials; and REGEN-004 which is Phase I clinical trial. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.
“ProKidney Corp. Earnings” Can Refer to the ProKidney Corp. Earnings Date
Some people say “ProKidney Corp. earnings” as a shortform way to refer to the earnings date.
For example, someone might say, “I plan to hold my ProKidney Corp. position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.
Owning ProKidney Corp. Stock on the Earnings Date
If you own ProKidney Corp. stock (PROK) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
A company’s earnings typically have a big impact on its stock price, which explains why the stock price for ProKidney Corp. might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.
There is often a big audience of investors involved with trading ProKidney Corp. shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.
These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.
Learning More ProKidney Corp. Earnings
You can contact us any time if you would like to ask questions about ProKidney Corp. earnings or anything else related to the stock market.